Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xbrane Biopharma AB (publ) | 23,801 | net | 14 Mar 2024 | tx 12+23,801 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 2,548 | 11.50 SEK | |
| 13 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 4,250 | 11.99 SEK | |
| 05 Sept 2023 | OTHER | Xbrane Biopharma AB (publ) | 3,000 | 0.22 SEK | |
| 05 Sept 2023 | GRANT_AWARD | Xbrane Biopharma AB (publ) | 3,000 | 0.00 SEK | deriv |
| 31 Aug 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 1,503 | 34.92 SEK | |
| 01 Jun 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 3,000 | 78.80 SEK | |
| 20 Feb 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 500 | 90.00 SEK | |
| 17 Feb 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 500 | 93.00 SEK | |
| 30 Dec 2022 | PURCHASE | Xbrane Biopharma AB (publ) | 1,000 | 78.38 SEK | |
| 10 Nov 2022 | PURCHASE | Xbrane Biopharma AB (publ) | 1,000 | 70.10 SEK | |
| 09 Aug 2022 | PURCHASE | Xbrane Biopharma AB (publ) | 2,000 | 86.00 SEK | first after silence |
| 20 Jan 2021 | PURCHASE | Xbrane Biopharma AB (publ) | 1,500 | 82.54 SEK |
1 purchase reported after at least 12 months of silence — most recent on 09 Aug 2022.